AI could help ovarian cancer patients get surgery at the right time
NCT ID NCT06839157
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses artificial intelligence to analyze data from over 1,000 people with advanced ovarian cancer. The goal is to create a tool that helps doctors decide whether to perform surgery right away or after chemotherapy. The research combines information from a previous clinical trial and real-world patient records to improve survival predictions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Perfect faces fuel surgery anxiety?
- AI vs. Doctor's intuition: which leads to better diagnoses?
- Can AI learn to grade endoscopy quality from video?
- Can a custom vaccine train the body to fight ovarian cancer?
- Can a 'Smart Bomb' drug outsmart recurrent ovarian cancer?
- Can a targeted drug boost standard ovarian cancer therapy?